Sino Biological

IPO

Global Leader in Recombinant Technology for Life Science

Public · Beijing, China · Founded 2007 · $29.0M raised

Headquarters
Beijing
Employees
501–1000
Founded
2007
Business Model
B2B
Total Funding
$29.0M
Last Round
$29.0M Series AMay 2018
Rounds
1
Type
Public

About

Sino Biological is an international reagent supplier and service provider specializing in independently developed recombinant proteins, antibodies, and cDNA clones for life science research. The company serves academic institutions, biotech firms, and pharmaceutical companies with one-stop technical services, including pre-clinical production for monoclonal antibody drug candidates, and operates from headquarters in Beijing with subsidiaries and production facilities in the United States, Europe, and Japan. Sino Biological employs over 900 research staff, including 230+ with master's or PhD degrees, across more than 279,800 sq ft of lab and office space.

Summary

Sino Biological is a Biotech company based in Beijing, China, founded in 2007. It has raised $29.0M in total across 1 round, most recently a $29.0M Series A round in May 2018. Investors include Qiming VP.

Funding History

IPOAug 2021
$681.0M

Sign up to see all 2 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sino Biological on Indexed.vc
<a href="https://indexed.vc/companies/sino-biological"><img src="https://indexed.vc/api/badge/company/sino-biological" alt="Sino Biological on Indexed.vc" width="260" height="76" /></a>